Clinical Trials Update: July 3, 2007
|
TOOLBOX
   Resize
COMMENT
 Discussion Policy
 CLOSE
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
Who's Blogging  |
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Vascular Diseases
This study will evaluate the effectiveness and safety of treatment with Sutent in people with unresectable or metastatic vascular sarcoma. Patients may be eligible if treated previously with one or two chemotherapy regimens, bevacizumab, or tyrosine kinase inhibitors. Candidates must be 18 or older and have a histopathologically-proven diagnosis of angiosarcoma, epithelioid sarcoma-like hemangioendothelioma, or Kaposis sarcoma. Additional criteria apply.
The research site is in New York City.
More information
Please see http:/
-----
Smoking Cessation
This seven-week outpatient study will evaluate an investigational medication to help people quit smoking. Participants must be ages 12 to 16, smoke at least three cigarettes a day, be physically healthy, and weigh at least 66 pounds.
The research site is in Houston, Texas.
More information
Please see http:/
![[slate.com logo]](http://media.washingtonpost.com/wp-dyn/content/graphic/2007/09/27/GR2007092701096.GIF)
